Longitudinal observational study of boxing therapy in Parkinson’s disease, including adverse impacts of the COVID-19 lockdown
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Longitudinal observational study of boxing therapy in Parkinson’s disease, including adverse impacts of the COVID-19 lockdown ; volume:21 ; number:1 ; day:24 ; month:8 ; year:2021 ; pages:1-10 ; date:12.2021
BMC neurology ; 21, Heft 1 (24.8.2021), 1-10, 12.2021
- Creator
-
Horbinski, Craig
Zumpf, Katelyn B.
McCortney, Kathleen
Eoannou, Dean
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-021-02359-6
- URN
-
urn:nbn:de:101:1-2021110918251607001189
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Horbinski, Craig
- Zumpf, Katelyn B.
- McCortney, Kathleen
- Eoannou, Dean
- SpringerLink (Online service)
Other Objects (12)
Lockdown effects on Parkinson’s disease during COVID-19 pandemic: a pilot study
Impact of social and mobility restrictions in Parkinson’s disease during COVID-19 lockdown
Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
Parkinson
Parkinson
Cardiovascular history and risk of idiopathic Parkinson’s disease: a cross-sectional observational study
Safety comparisons among monoamine oxidase inhibitors against Parkinson’s disease using FDA adverse event reporting system
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Lockdown effects on Parkinson’s disease during COVID-19 pandemic: a pilot study
Impact of social and mobility restrictions in Parkinson’s disease during COVID-19 lockdown
Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
Parkinson
Parkinson
Cardiovascular history and risk of idiopathic Parkinson’s disease: a cross-sectional observational study
Safety comparisons among monoamine oxidase inhibitors against Parkinson’s disease using FDA adverse event reporting system
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Lockdown effects on Parkinson’s disease during COVID-19 pandemic: a pilot study
Impact of social and mobility restrictions in Parkinson’s disease during COVID-19 lockdown
Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
Parkinson
Parkinson
Cardiovascular history and risk of idiopathic Parkinson’s disease: a cross-sectional observational study
Safety comparisons among monoamine oxidase inhibitors against Parkinson’s disease using FDA adverse event reporting system
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease